Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Low Back Pain Pipeline Drugs Market Report Overview
Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, injury, aging, arthritis, illness, and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such as NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants.
Key Mechanism of Actions | · Prostaglandin G/H Synthase 2 Inhibitor
· Prostaglandin G/H Synthase 1 Inhibitor · Cannabinoid Receptor 1 Agonist · Cannabinoid Receptor 2 Agonist · Mu Type Opioid Receptor Agonist |
Key Targets | · Prostaglandin G/H Synthase 2
· Prostaglandin G/H Synthase 1 · Mu Type Opioid Receptor · Alpha 2 Adrenergic Receptor · Cannabinoid Receptor 1 |
Key Routes of Administration | · Oral
· Intravenous · Intramuscular · Topical · Buccal |
Key Molecule Types | · Small Molecule
· Cell Therapy · Oligonucleotide · Synthetic Peptide |
Key Companies | · Allodynic Therapeutics LLC
· Adynxx Inc · Amplicore Inc · Axsome Therapeutics Inc · BioRestorative Therapies Inc · Bol Pharma |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Low Back Pain drugs in development market research report provides comprehensive information on the therapeutics under development for Low Back Pain, complete with an analysis of products by stage of development, target, and indication. It also provides a market assessment by mechanisms of action (MoA), route of administration (RoA), and molecule type. The report covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Low Back Pain and features dormant and discontinued projects.
Low Back Pain Pipeline Drugs Market Segmentation by Target
The key targets in the Low Back Pain pipeline drugs market are Prostaglandin G/H Synthase 2, Prostaglandin G/H Synthase 1, Mu Type Opioid Receptor, Alpha 2 Adrenergic Receptor, and Cannabinoid Receptor 1 among others. The majority of the pipeline drugs were Prostaglandin G/H Synthase 2 in 2022.
Low Back Pain Pipeline Drugs Market Analysis, by Target, 2022 (%)
Buy Full Report for More Target Insights Into The Low Back Pain Pipeline Drugs Market, Download a Free Report Sample
Low Back Pain Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action in the low back pain pipeline drugs market are Prostaglandin G/H Synthase 2 Inhibitor, Prostaglandin G/H Synthase 1 Inhibitor, Cannabinoid Receptor 1 Agonist, Cannabinoid Receptor 2 Agonist, and Mu Type Opioid Receptor Agonist among others. Prostaglandin G/H Synthase 2 Inhibitor led the market in 2022.
Low Back Pain Pipeline Drugs Market Analysis, by Mechanisms of Action, 2022 (%)
Buy Full Report for More MoA Insights into The Low Back Pain Pipeline Drugs Market, Download a Free Report Sample
Low Back Pain Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Low Back Pain pipeline drugs market are intravenous, intramuscular, topical, buccal, and oral among others. Most of the pipeline drugs followed the oral route of administration in 2022.
Low Back Pain Pipeline Drugs Market Analysis, by Routes of Administration, 2022 (%)
Buy Full Report for More Routes of Administration Insights into The Low Back Pain Pipeline Drugs Market, Download a Free Report Sample
Low Back Pain Pipeline Drugs Market Segmentation by Molecule Types
The leading molecule types in the Low Back Pain pipeline drugs market are small molecule, cell therapy, oligonucleotide, and synthetic peptide. The small molecule was the leading molecule type in the pipeline in 2022.
Low Back Pain Pipeline Drugs Market Analysis, by Molecule Types, 2022 (%)
Buy Full Report for More Molecule Type Insights Into The Low Back Pain Pipeline Drugs Market, Download a Free Report Sample
Low Back Pain Pipeline Drugs Market - Competitive Landscape
There companies involved in the development of low back pain drugs in the market are Allodynic Therapeutics LLC, Adynxx Inc, Amplicore Inc, Axsome Therapeutics Inc, BioRestorative Therapies Inc, and Bol Pharma among others. Allodynic Therapeutics LLC has the highest number of products under development among all these companies.
Low Back Pain Pipeline Drugs Market Analysis by Key Companies, 2022 (%)
Buy Full Report to Know More About The Low Back Pain Pipeline Drugs Market Companies, Download a Free Report Sample
Segments Covered in the Report
Low Back Pain Pipeline Drugs Market MoA Outlook
- Prostaglandin G/H Synthase 2 Inhibitor
- Prostaglandin G/H Synthase 1 Inhibitor
- Cannabinoid Receptor 1 Agonist
- Cannabinoid Receptor 2 Agonist
- Mu Type Opioid Receptor Agonist
Low Back Pain Pipeline Drugs Market Target Outlook
- Prostaglandin G/H Synthase 2
- Prostaglandin G/H Synthase 1
- Mu Type Opioid Receptor
- Alpha 2 Adrenergic Receptor
- Cannabinoid Receptor 1
Low Back Pain Pipeline Drugs Market RoA Outlook
- Oral
- Intravenous
- Intramuscular
- Topical
- Buccal
Low Back Pain Pipeline Drugs Market Molecule Types Outlook
- Small Molecule
- Cell Therapy
- Oligonucleotide
- Synthetic Peptide
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Low Back Pain (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Low Back Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Low Back Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Low Back Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Low Back Pain (Central Nervous System)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Low Back Pain (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Low Back Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Adynxx Inc
Allodynic Therapeutics LLC
Amplicore Inc
AnGes Inc
Axsome Therapeutics Inc
BioRestorative Therapies Inc
Bol Pharma
Camurus AB
Causeway Therapeutics Ltd
Creative Medical Technology Holdings Inc
Daewon Pharmaceutical Co Ltd
DongKoo Bio & Pharma Co Ltd
Eli Lilly and Co
Epione Therapeutics BV
Ethismos Research Inc
Evero Health Ltd
Gador SA
Hisamitsu Pharmaceutical Co Inc
Imbrium Therapeutics LP
Immune Pharmaceuticals Inc
Indaptus Therapeutics Inc
Laboratorios Silanes SA de CV
MD Biosciences GmbH
Mesoblast Ltd
Navipharm Co Ltd
Neumentum Inc
Pacira BioSciences Inc
Panacea Biotec Ltd
Persica Pharmaceuticals Ltd
Pfizer Inc
Rebus Holdings Inc
Scilex Holding Co
Sclnow Biotechnology Co Ltd
Shionogi & Co Ltd
Spine BioPharma LLC
Stayble Therapeutics AB
Sun Pharma Advanced Research Company Ltd
Tris Pharma Inc
Valenta Pharm
Vertanical GmbH
WEX Pharmaceuticals Inc
Xgene Pharmaceutical Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What target has the highest share in the Low Back Pain pipeline drugs market?
Most of the pipeline drugs belong to Prostaglandin G/H Synthase 2.
-
Which was the leading mechanism of action in the Low Back Pain pipeline drugs market?
Prostaglandin G/H Synthase 2 Inhibitor led the Low Back Pain pipeline drugs market in 2022.
-
Which was the leading route of administration in the Low Back Pain pipeline drugs market?
Most of the pipeline drugs followed the oral route of administration in 2022.
-
What are the key molecule types in the Low Back Pain pipeline drugs market?
The small molecule was the leading molecule type in the pipeline in 2022.
-
Which are the key companies in the Low Back Pain pipeline drugs market?
There companies involved in the development of low back pain drugs in the market are Allodynic Therapeutics LLC, Adynxx Inc, Amplicore Inc, Axsome Therapeutics Inc, BioRestorative Therapies Inc, and Bol Pharma among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.